This Article Full Text Full Text (PDF) All Versions of this Article: 51/3/767    most recent HYPERTENSIONAHA.107.102921v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laffer, C. L. Articles by Elijovich, F. Search for Related Content PubMed PubMed Citation Articles by Laffer, C. L. Articles by Elijovich, F. Related Collections Obesity Other hypertension Glucose intolerance Other etiology

(Hypertension. 2008;51:767.)
© 2008 American Heart Association, Inc.

Original Articles

The T8590C Polymorphism of CYP4A11 and 20-Hydroxyeicosatetraenoic Acid in Essential Hypertension

Cheryl L. Laffer; James V. Gainer; Michael R. Waterman; Jorge H. Capdevila; Michal Laniado-Schwartzman; Alberto Nasjletti; Nancy J. Brown; Fernando Elijovich

From the Texas A&M Health Science Center College of Medicine (C.L.L., F.E.), Temple, Tex; Vanderbilt University Medical Center (J.V.G., M.R.W., J.H.C., N.J.B.), Nashville, Tenn; and New York Medical College (M.L.-S., A.N.), Valhalla, NY.

Correspondence to Cheryl L. Laffer, Texas A&M Health Science Center College of Medicine, Scott and White–Hypertension/Nephrology, 2401 S 31st St, Temple, TX 76508. E-mail claffer{at}swmail.sw.org

A role for a deficit in transport actions of 20-hydroxyeicosatetraenoic acid (20-HETE) in hypertension is supported by the following: (1) diminished renal 20-HETE in Dahl-S rats; (2) altered salt- and furosemide-induced 20-HETE responses in salt-sensitive hypertensive subjects; and (3) increased population risk for hypertension in C allele carriers of the T8590C polymorphism of CYP4A11, which encodes an enzyme with reduced catalytic activity. We determined T8590C genotypes in 32 hypertensive subjects, 25 of whom were phenotyped for salt sensitivity of blood pressure and insulin sensitivity. Urine 20-HETE was lowest in insulin-resistant, salt-sensitive subjects (F=5.56; P<0.02). Genotypes were 13 TT, 2 CC, and 17 CT. C allele frequency was 32.8% (blacks: 38.9%; whites: 25.0%). C carriers (CC+CT) and TT subjects were similarly distributed among salt- and insulin-sensitivity phenotypes. C carriers had higher diastolic blood pressures and aldosterone:renin and waist:hip ratios but lower furosemide-induced fractional excretions of Na and K than TT. The T8590C genotype did not relate to sodium balance or pressure natriuresis. However, C carriers, compared with TT, had diminished 20-HETE responses to salt loading after adjustment for serum insulin concentration and resetting of the negative relationship between serum insulin and urine 20-HETE to a 1-µg/h lower level of 20-HETE. The effect of C was insulin independent and equipotent to 18 µU/mL of insulin (20-HETE= 2.84–0.054xinsulin–0.98xC; r²=0.53; F=11.1; P<0.001). Hence, genetic (T8590C) and environmental (insulin) factors impair 20-HETE responses to salt in human hypertension. We propose that genotype analyses with sufficient homozygous CC will establish definitive relationships among 20-HETE, salt sensitivity of blood pressure, and insulin resistance.

Key Words: hypertension • obesity • arachidonic acid • cytochrome P450 • insulin • insulin resistance

This article has been cited by other articles:

				K. Inoue, K. Sodhi, N. Puri, K. H. Gotlinger, J. Cao, R. Rezzani, J. R. Falck, N. G. Abraham, and M. Laniado-Schwartzman Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE Am J Physiol Renal Physiol, October 1, 2009; 297(4): F875 - F884. [Abstract] [Full Text] [PDF]

				F. Elijovich and C. Laffer A role for single-pill triple therapy in hypertension Therapeutic Advances in Cardiovascular Disease, June 1, 2009; 3(3): 231 - 240. [Abstract] [PDF]

				P. W. Sanders Dietary Salt Intake, Salt Sensitivity, and Cardiovascular Health Hypertension, March 1, 2009; 53(3): 442 - 445. [Full Text] [PDF]

				J. M. Williams, A. Sarkis, K. M. Hoagland, K. Fredrich, R. P. Ryan, C. Moreno, B. Lopez, J. Lazar, F. J. Fenoy, M. Sharma, et al. Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1764 - F1777. [Abstract] [Full Text] [PDF]

				C. Fava, M. Montagnana, P. Almgren, L. Rosberg, G. Lippi, B. Hedblad, G. Engstrom, G. Berglund, P. Minuz, and O. Melander The V433M Variant of the CYP4F2 Is Associated With Ischemic Stroke in Male Swedes Beyond Its Effect on Blood Pressure Hypertension, August 1, 2008; 52(2): 373 - 380. [Abstract] [Full Text] [PDF]